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Abstract
Deviations from assigned treatment occur often in clinical trials. In such a setting, the
traditional intent-to-treat analysis does not measure biological efficacy but rather programmatic
effectiveness. For all-or-nothing compliance situation, Loeys and Goetghebeur (2003) recently
proposed a Structural Proportional Hazards method. It allows for causal estimation in the
complier subpopulation provided the exclusion restriction holds: randomization per se has no
effect unless exposure has changed. This assumption is typically made with structural models for
noncompliance but questioned when the trial is not blinded. In this paper we extend the structural
PH model to allow for an effect of randomization per se. This enables analyzing sensitivity of
conclusions to deviations from the exclusion restriction. In a colo-rectal cancer trial we find the
causal estimator of the effect of an arterial device implantation to be remarkably insensitive to
such deviations.
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1 Introduction
While the randomized clinical trial remains the gold standard design for causal inference,
a thorough analysis of the impact of an intervention should consider treatment actually
received besides treatment assigned. The distance between intended and materialized
treatments can indeed vary widely, first inside the trial and later under less controlled
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conditions. Hence the challenge to estimate the effect of different levels of treatment that
occur in practice.
The hazard ratio has become the most popular measure of the effect of treatment
on survival. Intention-to-treat results are typically cast in those terms, the theory has
been well developed and resulting estimators well understood. On the other hand,
structural accelerated failure time models (SAFT) as proposed by Robins and Tsiatis
(1991) have become the usual tools for ‘causal survival analysis’ conditional on observed
exposures. These models express how survival time can be shrunk or expanded by
a parametric function of observed exposures to yield potential treatment-free survival
times. In the absence of a direct effect of randomization, potential treatment-free
survival times are by design equally distributed between randomized arms. To tap into
the proportional hazards tradition and allow for a smooth exchange of information,
Loeys and Goetghebeur (2003) developed structural proportional hazards models. They
analyzed ECOG-trial E9288 (Kemeny et al., 2002), a randomized clinical trial in
colorectal cancer patients with liver metastases. This ECOG multi-centre trial was
initiated because the long-term outcome of resection of hepatic metastases remained
poor and arterial chemotherapy regimens targeted to the liver had demonstrated high
potential. Patients were randomly assigned to either surgical resection alone (control
arm, 56 patients) or surgical resection followed by chemotherapy (experimental arm,
53 patients). Interest focused on comparing 5-year survival with and without the
implantation. The multi-centric nature of the study made preoperative randomization the
practical option. As a result, ten patients who were randomized to receive experimental
treatment, did not receive the arterial device implantation, possibly for reasons related to
their survival chance.
At the First Barcelona Workshop on Survival Analysis, Ross Prentice raised
questions concerning the exclusion restriction given the unblinded nature of the study.
It is not inconceivable for instance that the bad news of not being able to receive the
implant once it was planned had a negative effect on the patients outcome. Likewise,
surgery involving an intended implant might be scheduled earlier in the day, which may
have its own impact on survival etc. In response to such concerns this paper sets out to
conduct a sensitivity analysis as follows.
In Section 2 we provide a rationale for causal methodology in a proportional
hazards framework. Section 3 details the structural proportional hazards approach under
the exclusion restriction. In Section 4 we extend the model and adapt the estimation
procedure to allow for a sensitivity analysis and examine the impact of violations of the
exclusion restriction on the causal PH-estimator. In Section 5 we move on to investigate
the joint effect of assignment in both the noncompliant (‘the exclusion effect’) and
compliant (‘the causal effect’) subpopulation. The methodology is applied to the E9288-
data in Section 6 and discussed in Section 7.
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2 Rationale for a causal proportional hazards estimator
When clinical trial participants fail to adhere to their assigned treatment, a
straightforward but naive estimator of the effect of treatment actually received compares
patients who were observed to receive the experimental exposure with those who did
not. Consider specifically the Cox model
h(t | Ei) = h0(t)exp(β0Ei), (1)
where Ei is the all-or-nothing exposure indicator and h(t | Ei) is the hazard rate for
failure at time t given exposure. When compliance is selective, i.e. when individuals
who comply are prognostically different from those who do not, the parameter β0 carries
no causal interpretation.
Therefore the most commonly used approach is an intent-to-treat analysis. In
proportional hazard terms:
h(t | Ri) = h0(t)exp(γ0Ri), (2)
where Ri = 1 indicates the experimental arm. The advantage of this approach is its
validity under the null. When experimental treatment has no effect, survival distributions
coincide on both randomized arms and γ0 = 0 corresponds to the true model. However,
in the presence of non-compliance, γ0 does not generally measure the biological effect
of treatment but rather mixes the effect on compliers with the absence of effect on non-
compliers.
To estimate the causal effect of treatment actually received, structural models can be
used. Loeys and Goetghebeur (2003) consider
h(t | Ri = 1,Ui = u) = h(t | Ri = 0,Ui = u)exp(ψ0u) (3)
whereUi is the potential all-or-nothing exposure for the ith subject, that is the exposure
that would have been observed had subject i been randomized to experimental treatment.
Ui is observed on the experimental arm but latent on the control arm. The Causal
Proportional Hazards Effect of Treatment (C-PROPHET) is the log hazard ratio ψ0 in
model (3). It compares survival under experimental and potential control conditions
in the treatable subgroup {Ui = 1}. A negative (respectively positive) ψ0 implies a
beneficial (respectively harmful) effect of implantation in the treatable subset.
In the subgroup {Ui = 0} that would not have been treated when assigned to
experimental treatment, no effect of assignment on survival is assumed. Imbens and
Rubin (1997) call this assumption the ‘exclusion restriction’, while Pearl (2002) calls this
‘the absence of indirect effect’. The main challenge for inference in model (3) stems from
Ui being unobserved in the control arm. We summarize in the next section how ψ0 can
be estimated under the exclusion restriction despite ignoring this potential compliance
information.
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3 Inference for the C-PROPHET estimator
If potential receivers of the experimental exposure were known at baseline in both arms,
one would fit a proportional hazards model in the subgroup {Ui = 1}. Denote then
Breslow’s cumulative baseline hazard estimator for survival in the {Ri = 0,Ui = 1}-
group by Hˆ01(t). Within the {Ui = 1}-subset the partial likelihood score equation can be
rewritten - in the absence of ties - as
∑
t( j)
[
R( j)−
{
Ĥ01(t( j))− Ĥ01(t( j−1))
}
n11 je
ψ0
]
= 0 (4)
where t( j) is the j-th ordered failure time in the treatable subset and R( j) the
corresponding assignment indicator. It thus suffices to estimate the jumps of the
cumulative hazard for the unobserved subset of compliers in the control arm. H01 can
be estimated via the corresponding survival estimator Sˆ∗01(t),
Ŝ∗01(t) = {Ŝ0(t)− (1− p̂i)Ŝ10(t)}/p̂i, (5)
with Sr(t) := Pr(Ti > t | Ri = r), Sru(t) := Pr(Ti > t | Ri = r,Ui = u), and p̂i the observed
compliance proportion in the experimental arm. The Kaplan-Meier estimates Ŝ0(t) and
Ŝ10(t) will be consistent under independent censoring or the weaker assumption that
censoring is non-informative for the control arm as a whole, while in the experimental
arm censoring is non-informative conditional on treatment exposure. Frangakis and
Rubin (1999) argue that it is sometimes more reasonable to assume non-informative
censoring on potential treatment exposure in both arms, and showed that even under this
scenario S01(t) is identifiable. Because Ŝ
∗
01(t) is not necessarily monotonic decreasing
and found to be a poor estimator for S01(t), Loeys and Goetghebeur (2002) suggested
to improve on the proposed estimator via isotonic regression and the ‘Pool-Adjacent-
Violators’ Algorithm (Barlow et al., 1972). To avoid ties in bootstrap samples (Efron,
1981), the jackknife procedure is proposed for variance estimation. Simulation revealed
that this procedure provides a somewhat conservative variance estimator in this setting.
4 The exclusion restriction: a sensitivity analysis
The exclusion restriction implied by model (3) disallows an effect of assignment for
(potential) non-receivers. While this is plausible in double-blind settings, our motivating
example E9288 was unblinded.
Consider therefore the following pair of causal models:{
h(t | Ri = 1,Ui = 0) = h(t | Ri = 0,Ui = 0)exp(η0)
h(t | Ri = 1,Ui = 1) = h(t | Ri = 0,Ui = 1)exp(ψ0)
(6)
In the treatable subset {Ui = 1} we consider a proportional hazards effect of exposure
as before, but in the {Ui = 0}-subset we no longer require equality in distribution
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between randomized arms. Instead, a positive η0 in (6) implies that omission of an
implantantion that was assigned is bad news added to bad news, i.e. observing the
inability of an implant on the experimental arm deteriorates the already bad survival
prognosis compared to not observing this on the control arm. This additionally imposed
proportional hazard assumption in the {Ui = 0}-subset can be rewritten in terms of the
survival distributions:
S00(t) = S10(t)
exp(−η0). (7)
Using equality (7), we obtain a treatment-free survival curve for potential compliers from
Ŝ∗01(t;η0) = {Ŝ0(t)− (1− p̂i)Ŝ10(t)
exp(−η0)}/p̂i. (8)
As before, the pointwise estimator need not be monotone and isotonic regression on
time yields our estimator Sˆ01(t;η0). Upon substituting the monotonized Sˆ01 to obtain
H˜01(t;η0) =− log Ŝ01(t;η0), we estimate ψ0 in function of η0 as
exp(ψˆ0(η0)) =
∑t( j) R( j)
∑t( j)
{
H˜01(t( j);η0)− H˜01(t( j−1);η0)
}
n11 j
. (9)
5 Joint estimation of effect in the compliant and noncompliant subpopulation
In the previous section ψ0 is estimated as a function of a fixed sensitivity parameter η0.
Next we investigate joint estimation of η0 and ψ0.
The estimation procedure outlined in Section 3 is restricted to all-or-nothing
compliance. Indeed, when several levels of compliance are involved, the survival
distribution S01(t) is no longer identified without strong additional assumptions.
Recently, Loeys and Goetghebeur (2002) proposed an alternative estimation procedure
that overcomes this limitation. Specifically, they backtransform observed survival
distributions in the experimental arm by exponential functions of the measured exposures
to obtain treatment-free survival distributions. Averaging these over all complier
subgroups yields an unconditional treatment-free survival curve in the treatment arm.
Under the exclusion restriction this should match the corresponding curve on the control
arm. Allowing now for an effect of assignment in the {Ui = 0}-group as in model (6),
the idea is to check whether the distribution of observed survival times in the control
arm is close to the new mixture of backtransformed survival distributions observed in
the experimental arm:
S1 0(t;η,ψ) = Sˆ10(t)
exp(−η)(1− pˆi)+ Sˆ11(t)
exp(−ψ)pˆi. (10)
Parameter values η and ψ which ‘equalize’ the treatment-free survival distributions
between randomized arms are point estimators for η0 and ψ0. Because we are estimating
two parameters here, two estimating equations are needed. Loeys and Goetghebeur
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(2002) combine a logrank and weighted logrank test statistic which are built as sums
of ‘pseudo’ martingale residuals. As the test statistic Q(η,ψ) is approximately χ2(2),
a 95% confidence region for (η0,ψ0) is formed by the set of (η,ψ)-values for which
Q(η,ψ) is below 6.0.
In practice the information may be weak and identification of both η0 and ψ0 over-
ambitious. Small scale simulations confirm that with limited selectivity (i.e. receivers
and non-receivers having a comparable baseline survival prognosis) identifiability
problems indeed occur. However with an increasing selection effect both ‘causal’ effects
were reasonably well identified in the simulation setting. Results on the dataset E9288
are described next.
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Figure 1: 3 approaches: (1) As treated (2) Intent-to-treat (3) C-PROPHET.
Note: AD stands for Arterial Device).
6 The causal effect of an arterial device implantation
In this section we analyze the E9288-data. Within the 5-year follow-up, 30 patients
(54%) died on the control arm compared to 33 patients (62%) on the experimental
arm. Figure 1 shows results following models (1), (2) and (3). The as-treated analysis
estimates a non-significant beneficial effect of implantation but is only valid under the
assumption that non-receivers on the experimental arm form a random subset from
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the entire population. The estimated effect under the intent-to-treat analysis reveals
a non-significant harmful effect of assignment, but does not capture the effect of the
implantation actually received. The structural analysis reveals a 43% increase in hazard
associated with arterial device implantation in the treatable subset. The latter is derived
under the exclusion restriction. Under this assumption, it is further shown in Loeys
and Goetghebeur (2003) how the selectivity of patients getting the intervention can
be presented by contrasting Ŝ01, as estimated in (5) with Ŝ10 = Ŝ00, as observed in
non-compliers in the experimental arm. That plot revealed that patients who would not
have received the intervention when assigned to it have a much worse intervention-free
survival prognosis than patients that would have received the intervention. This selection
effect is also seen in the as-treated estimator, which mixes the causal treatment effect
in the treatable subgroup with a diluted selectivity effect, and thus differs from the C-
Prophet estimator.
Following Section 4 we can now investigate how sensitive the C-PROPHETestimator
is to violations of the exclusion restriction. From Figure 2, we learn that under
the assumption of a 50% decrease (respectively increase) in hazard associated with
implantation assignment in the untreatable subset, the estimated causal effect equals 1.53
with 95% confidence interval ranging from 0.72 to 3.25 (respectively 1.36, with 95%
CI: 0.68− 2.77). We thus observe that quite substantial deviations from the exclusion
restriction have rather limited impact on the estimated causal hazard ratio. Relative to
the width of the 95% confidence interval, the change in causal effect as a function of the
sensitivity parameter is indeed quite small.
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Figure 2: The causal hazard ratio exp(ψ0) (with 95% confidence interval) as a
function of the sensitivity parameter exp(η0).
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Figure 3: Joint estimation of the sensitivity hazard ratio exp(η0) and causal
hazard ratio exp(ψ0).
Results of joint estimation of η0 and ψ0 as outlined in Section 5 are summarized in
Figure 3. Contour plots show the value of the χ2(2)-test statistic Q(η,ψ) as a function
of exp(η) and exp(ψ). Point estimators for exp(η0) and exp(ψ0) equal 6.63 and 1.19.
As the 95% confidence region does not close for increasing values of η, identifiability
of η0 is rather poor, in contrast to that of ψ0. Nevertheless the data appear to favour the
region of η suggesting that bad news add more bad news. A substantial positive effect of
an intended but absent implant is excluded as a possibility. Surprisingly however we see
negligeable impact on estimation of the primary parameter. A marginal 95% confidence
interval for η0 and ψ0 can be found upon projecting the 3.84-contour on the axes (Robins
and Greenland, 1994).
7 Discussion
In this paper we presented two approaches to investigate violations against the exclusion
restriction in a causal proportional hazards framework. While the approach presented
in Section 4 is limited to all-or-nothing compliance, the approach of Section 5 allows
for several compliance levels. As identifiability under the second approach relies on
the unobserved selectivity, one should be careful when interpreting its results. In a
missing data setting Scharfstein (2002) recently discovered that when the signal for
inference on η0 is weak, it is dangerous to believe the η-estimate. He therefore favors
a sensitivity approach as proposed in Section 4. Interestingly, Scharfstein (2002) found
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narrow confidence intervals conditional on η relative to an enormous range of point
estimates for ψ as η varies. In contrast we obtain in our motivating example, despite
a non-negligeable portion of observed non-compliers on the experimental arm (10 out
of 53), changes in the outcome distribution of potential non-receivers with a relatively
small impact on the causal parameter estimates.
Further research would be welcomed on the role baseline predictors for treatment-
free survival and/or exposure. In as treated model (1) we cannot expect to capture the
dependence between treatment-free survival and potential experimental compliance by
conditioning on these baseline covariates, and the as treated approach will still give
biased results. Loeys and Goetghebeur (2002) propose an estimation procedure allowing
to identify population-averaged Causal PROPortional Hazards Effects of Treatment at
observed exposure and covariate levels. Conditioning on baseline covariates in model (3)
can then address confounding (in the presence of imbalance between randomized arms),
conservatism and/or help to keep censoring non-informative.
Finally it is worth remembering that our approach studies survival models conditional
on exposure status. Marginal proportional hazards models have recently been introduced
by Hernan, Brumback and Robins (2000).
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Resum
Les desviacions del tractament assignat so´n comuns en assajos clı´nics. En aquest context,
l’ana`lisi tradicional per intencio´ de tractar no mesura l’efica`cia biolo`gica sino´ l’efica`cia de
la programacio´. Per a aquelles situacions on el compliment e´s total o nul, Loeys and
Goetghebeur (2003) proposen un me`tode estructural de riscos proporcionals. Aquest me`tode
permet l’estimacio´ causal en la subpoblacio´ que compleix, sempre que es verifiqui la restriccio´
d’exclusio´: l’aleatoritzacio´ per se no te cap efecte llevat que es canviı¨ l’exposicio´. Aquesta
premissa s’usa en general amb models estructurals per a incompliment pero` es qu¨estiona quan
l’assaig no e´s cec. En aquest treball estenem el model estructural de riscos proporcionals de
manera que admeti un efecte d’aleatorizacio´ per se. Aixo` ha de permetre analitzar la sensibilitat
de les conclusions a les desviacions de la restriccio´ d’exclusio´. A un assaig clı´nic sobre ca`ncer
colo-rectal trobem que l’estimador causal de l’efecte de la implantacio´ d’un dispositiu arterial e´s
remarcablement insensible a aquestes desviacions.
MSC: 62N01, 62N02, 62P10, 92B15
Paraules clau: Ana`lisi de sensibilitat; assajos clı´nics aleatoritzats; compliment; infere`ncia causal;
restriccio´ d’exclusio´; riscos proporcionals
